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The positive regulatory machinery in the microRNA (miRNA) processing pathway is relatively well characterized,
but negative regulation of the pathway is largely unknown. Here we show that a complex of nuclear factor 90 (NF90)
and NF45 proteins functions as a negative regulator inmiRNA biogenesis. PrimarymiRNA (pri-miRNA) processing
into precursor miRNA (pre-miRNA) was inhibited by overexpression of the NF90 and NF45 proteins, and consid-
erable amounts of pri-miRNAs accumulated in cells coexpressing NF90 and NF45. Treatment of cells overexpress-
ing NF90 and NF45 with an RNA polymerase II inhibitor, -amanitin, did not reduce the amounts of pri-miRNAs,
suggesting that the accumulation of pri-miRNAs is not due to transcriptional activation. In addition, the NF90 and
NF45 complex was not found to interact with the Microprocessor complex, which is a processing factor of pri-
miRNAs, but was found to bind endogenous pri-miRNAs. NF90-NF45 exhibited higher binding activity for pri-let-7a
than pri-miR-21. Of note, depletion of NF90 caused a reduction of pri-let-7a and an increase of mature let-7a
miRNA, which has a potent antiproliferative activity, and caused growth suppression of transformed cells. These
findings suggest that the association of the NF90-NF45 complex with pri-miRNAs impairs access of the Micropro-
cessor complex to the pri-miRNAs, resulting in a reduction of mature miRNA production.
MicroRNAs (miRNAs) constitute a class of noncoding small
RNAs that function as repressors for eukaryotic gene regula-
tion by binding to the 3 untranslated regions of target mRNAs
(2). This binding causes mRNA cleavage or translational inhi-
bition of the mRNA, depending upon the degree of comple-
mentarity. The lengths of miRNAs are 21 to 23 nucleotides
(nt), and over 500 miRNAs have been discovered in mammals.
miRNAs regulate the expression of a large number of genes
(38) that are involved in cell proliferation, apoptosis, hemato-
poietic differentiation, viral infection, and tumorigenesis (4, 5,
7, 22, 26, 32, 39, 45).
In mammals, miRNA genes are transcribed by RNA poly-
merase II as primary miRNAs (pri-miRNAs) (36). These pri-
miRNAs are processed into precursor miRNAs (pre-miRNAs)
by the Microprocessor complex (8, 13, 20, 31, 33). Another
complex comprised of exportin-5 and RanGTP transports the
pre-miRNAs from the nucleus to the cytoplasm (3, 40, 58). In
the cytoplasm, Dicer, a cytoplasmic RNase III enzyme, cleaves
the pre-miRNAs to approximate 22-nt mature miRNA du-
plexes with 2-nt 3 overhangs (14, 24, 28). One strand of the
duplex is incorporated into the RNA-induced silencing com-
plex (12, 19, 29, 41, 51). The single strand of RNA guides the
RNA-induced silencing complex to the target mRNA with
sequence complementarity, which leads either to mRNA cleav-
age or to translational repression (12, 24, 41, 44).
The Microprocessor complex, which cleaves pri-miRNA to
pre-miRNA during miRNA biogenesis, is comprised of a nu-
clear RNase III enzyme, Drosha, and its cofactor, DGCR8 (8,
13, 20). In addition to the Microprocessor complex, excessively
expressed Drosha forms other larger complexes composed of a
multitude of different RNA binding proteins (13). A family of
the larger Drosha complex is the double-stranded RNA bind-
ing motif (dsRBM) proteins, including DGCR8, nuclear factor
90 (NF90), and NF45 (13). DGCR8 is an essential factor for
the Drosha-mediated pri-miRNA processing reaction (13, 20).
However, the functions of NF90 and NF45 in pri-miRNA
processing remain unclear.
The NF90 family proteins consist of several different but
closely related proteins generated through alternate splicing.
Members of this family include NF90a/b and its longer form,
NF110a/b. NF90b and NF110b have an NVKQ insert between
their two dsRBMs, whereas NF90a and NF110a lack this in-
sert. These proteins are identical at the N-terminal and central
regions but diverge at their C-terminal regions (46). The cen-
tral region includes a functional nuclear localization signal and
two dsRBMs. In contrast, NF45 possesses a zinc-finger nucleic
acid binding domain (DZF) and a glutamic acid-rich region.
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The NF90 family and NF45 proteins form a heterodimer and
are predominantly localized in the nucleus.
NF90 and NF45 were first isolated as nuclear factors that
bind to a cis element of the interleukin-2 promoter, known as
an antigen receptor response element in the activated Jurkat
T-cell line (27). Independently, we previously identified NF90
as a binding factor that recognizes a unique palindromic se-
quence in the DNase I-hypersensitive site of the HLA-DR
gene in monocytic leukemia THP-1 cells (47). The NF90 family
proteins are also known to bind to a minihelix RNA derived
from adenovirus VA RNA (17). Interestingly, the secondary
structures of both the palindromic sequence within the HLA-
DR gene and the minihelix RNA are predicted to be small
double-stranded structures, similar to the structures of miRNA
precursors (pri- and pre-miRNA).
As mentioned above, the NF90 and NF45 proteins associate
with overexpressed Drosha, and NF90 favorably binds to the
small double-stranded structures contained in the miRNA pre-
cursors. Therefore, NF90 and NF45 are highly likely to be
involved in miRNA biogenesis, especially during processing of
pri-miRNAs into pre-miRNAs. To investigate this possibility,
we have examined the functions of the NF90 and NF45 pro-
teins in the pri-miRNA processing step. Using an in vitro
pri-miRNA processing assay, we found that forced expression
of NF90 and NF45 inhibited the cleavage of pri-miRNAs into
pre-miRNAs. Furthermore, pri-miRNAs accumulated in cells
that coexpressed NF90 and NF45. In vivo binding analyses
demonstrated that NF90 did not interact with the endogenous
Drosha-DGCR8 complex, but the NF90-NF45 complex was
bound to endogenous pri-miRNAs. Furthermore, this protein
complex exhibited a higher affinity for pri-let-7a than pri-
miR-21 in vitro. Interestingly, knockdown of NF90 caused a
decrease in pri-let-7a and an increase in mature let-7a. There-
fore, we propose that the association of the NF90-NF45 com-
plex with pri-miRNAs may impair access of the Microproces-
sor complex to pri-miRNAs, resulting in the inhibition of the
mature miRNA production.
MATERIALS AND METHODS
Sequences of all the oligonucleotides and PCR protocols are listed in Table S1
of the supplemental material.
Cells, plasmids, and antibodies. Human embryonic kidney 293T cells and 293
cells were maintained in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal calf serum. For expression of Flag-tagged NF90a, NF90b,
NF110a, or NF110b proteins, cDNA fragments corresponding to the full length
of these proteins were obtained by PCR from pcDNA3.1-NF90a,- NF90b,
-NF110a, and -NF110b plasmids (provided by M. B. Mathews, University of
Medicine and Dentistry of New Jersey, Newark). The cDNA fragments were
subcloned into the EcoRI sites of the pcDNA3-Flag vector. To construct the
Flag-tagged NF45 protein, a full-length NF45 cDNA was PCR amplified from
HeLa cell cDNA and inserted into the EcoRI and XhoI sites of the pcDNA3-
Flag vector. To construct an expression plasmid of Drosha, a full-length Drosha
cDNA was obtained by PCR from HeLa cell cDNA and subcloned into BamHI
and EcoRV sites of the pcDNA3.1 vector. Anti-Drosha, anti-DGCR8, anti-
Ku70, and antitubulin antibodies were obtained from Upstate Biotechnology,
ProteinTech Group, Inc., Santa Cruz Biotechnology, and CalBiochem, respec-
tively. Anti-NF90 antibody was produced by immunizing New Zealand White
rabbits with glutathione S-transferase–NF90 (residues 419 to 604) as previously
described (53).
Transfections. 293T cells were transfected using Lipofectamine Plus reagent
according to the manufacturer’s instructions (Invitrogen).
In vitro pri-miRNA processing assay. An in vitro pri-miRNA processing assay
was performed as described by Lee et al. (35) with some modifications. Briefly,
pri-miR-30a was amplified from 293T cDNA by PCR. The PCR product was
subcloned into the pGEM-T-easy vector (Promega). The plasmid was linearized
with SpeI and used for in vitro transcription to make a 32P-radiolabeled RNA
probe. Whole-cell extracts (WCEs) were prepared from 293T cells by sonication
in lysis buffer (20 mM HEPES-KOH, pH 8.0, 100 mM KCl, 0.2 mM EDTA, 5%
glycerol, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride [PMSF]),
followed by centrifugation. Each 30-l reaction mixture contained the radiola-
beled RNA probe, 100 g of WCE, 1 U RNase Out (Invitrogen), and 6.4 mM
MgCl2 in reaction buffer (20 mM HEPES-KOH, pH 8.0, 100 mM KCl, 0.2 mM
EDTA, 5% glycerol). After incubation of the mixture at 37°C for 90 min, the
resulting RNA was extracted and electrophoresed on a 12% denaturing poly-
acrylamide gel. The processed miRNAs were visualized by autoradiography.
Intensities of the produced pre-miR-30a were measured using a BAS 2000
imaging system (Fuji Film).
Western blot analysis. Western blot analysis was performed as previously
described (48).
RNA interference. For the RNA interference experiment, 293 cells were trans-
fected with small interfering RNAs (siRNAs) using Lipofectamine RNAiMAX
according to the manufacturer’s instructions (Invitrogen). siRNA duplexes tar-
geting the NF90 family proteins were obtained from Invitrogen. As a negative
control, Negative Universal Control Med (Invitrogen) was used.
qRT-PCR analysis. Total RNA was prepared by using TRIzol according to the
manufacturer’s instructions (Invitrogen). RNA was treated with DNase I (Am-
bion) for 20 min at 37°C, and DNase I was inactivated using DNase I Inactive
reagent (Ambion). Two micrograms of DNase I-treated RNA was used to syn-
thesize cDNA using a cDNA synthesis kit (Invitrogen). For quantitative reverse
transcription-PCR (qRT-PCR), the PCR sample was comprised of diluted (1/
160) cDNA, QuantiTect SYBR green PCR master mix (Qiagen), and 1 mM each
of forward and reverse primers in a total volume of 12.5 l. PCRs were per-
formed on a DNA Engine OPTICON 2 (MJ Research) using a cycling program.
SYBR green PCR master mix (Applied Biosystems) was used when PCRs were
performed on an ABI 7000 sequence detection system (Applied Biosystems). All
runs included the -actin gene as an internal control. Samples were normalized
to -actin RNA, giving arbitrary values representing a ratio of experimental to
control results. Results are expressed as relative mRNA levels. qRT-PCR for
detection of miRNA was carried out using a TaqMan MicroRNA assay kit
(Applied Biosystems) according to the manufacturer’s protocol. RNU6B small
nuclear RNA was used as an internal control in the qRT-PCR to normalize RNA
input.
Immunocytochemical staining. Immunocytochemical staining was performed
as described by Muraki et al. (43). The primary and secondary antibodies used
were anti-NF90 antibody (10 g/ml) and fluorescein isothiocyanate-conjugated
goat anti-rabbit immunoglobulin G (IgG; 1:1,000; ICN), respectively. 4,6-
diamidino-2-phenylindole (DAPI) was used for nuclear staining. Stained cells
were mounted with ProLong Gold antifade reagent (Invitrogen). Images were
taken using a fluorescence microscope (Axiophoto; Carl Zeiss).
Immunoprecipitation. WCEs were prepared by lysing cells in 50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 0.1 mM PMSF, and protein
inhibitor cocktail (Roche) and immunoprecipitated with anti-Drosha antibody or
normal rabbit IgG. Immunoprecipitates were separated by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (PAGE) and transferred to a polyvinyli-
dene difluoride membrane. The membrane was probed with anti-Drosha, anti-
DGCR8, or anti-NF90 antibodies. Following incubation, the membrane was
washed and incubated with peroxidase-conjugated anti-rabbit IgG and subse-
quently developed by chemiluminescence using Western Lightning (Perkin-
Elmer).
Blue native PAGE. Cells were resuspended with 1 sample buffer (Invitrogen)
including 1% n-dodecyl--D-maltoside and incubated for 15 min at 0°C. After
centrifugation (15,000  g) at 4°C for 20 min, the supernatants were collected as
WCEs. The WCEs were mixed with 0.25% G-250 sample additive (Invitrogen)
and subjected to electrophoresis on a native PAGE 4 to 16% bis-Tris gel (In-
vitrogen) and analyzed by Western blotting.
Detection of the interaction between the NF90-NF45 complex and pri-miRNA
in vivo. WCEs from cells were immunoprecipitated with anti-FLAG affinity gel
(Sigma), and the coprecipitated RNA was purified by proteinase K digestion,
extracted with phenol-chloroform, and ethanol precipitated. The precipitated
RNA was annealed with 250 ng/l random hexamers and reverse transcribed
with the Reverse SuperScript III first-strand synthesis system (Invitrogen).
cDNA was amplified by PCR using the specific primers for pri-miRNA. The
primer sequences are described in Table S1 of the supplemental material.
Preparation of recombinant proteins. The full-length (FL) cDNAs of NF90
and NF45 were synthesized by PCR using pcDNA3.1-NF90b and pcDNA3.1-
NF45 as templates, respectively. The DGCR8 FL cDNA was obtained by PCR
using HeLa cDNA as a template. The PCR products were subcloned into pIVEX
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2.4d (Roche). The dsRNA-binding domains (dsRBDs) of DGCR8 (residues 484
to 773) were generated by PCR using pIVEX 2.4d-DGCR8 FL as a template.
The PCR product was subcloned into pIVEX 2.4d. The pIVEX 2.4d-NF90, the
pIVEX 2.4d-DGCR8 FL, and the pIVEX 2.4d-DGCR8 dsRBDs were trans-
formed into Escherichia coli Origami(DE3) pLacI (Novagen) and the pIVEX
2.4d-NF45 was transformed into E. coli BL21(DE3, rep4). After induction with
isopropyl--D-thiogalactopyranoside, clones were resuspended in 50 mM KPB,
pH 7.0, and 300 mM NaCl, followed by sonication on ice. After centrifugation,
the supernatants were loaded on a TALON metal affinity column (Clontech).
Recombinant proteins were eluted with the same buffer including 200 mM
imidazole. The eluted proteins were dialyzed against 20 mM Tris-HCl, pH 7.5,
100 mM NaCl, 1 mM dithiothreitol, 10% glycerol, and 0.5 mM PMSF and were
stored at 80°C until use.
EMSAs. pri-let-7a-1, pre-let-7a-1, and pri-miR-21 were amplified from 293T
cDNA by PCR with specific primers. The PCR products were subcloned into the
pGEM-T-easy vector (Promega). The plasmids were linearized with SpeI and
used for in vitro transcription to make 32P-radiolabeled RNA probes. An elec-
trophoretic mobility shift assay (EMSA) was performed in a 20-l reaction
mixture containing 50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 5% glycerol, 2 mM
MgCl2, 0.2% bovine serum albumin, 20 units of RNase Out (Invitrogen), 30 g
yeast Saccharomyces cerevisiae tRNA, and 25,000 cpm labeled probe. The
mixture was incubated at 0°C for 15 min and then electrophoresed on a 4%
polyacrylamide gel containing 10% glycerol in 0.5 Tris-borate-EDTA. For
supershift assays, recombinant proteins were preincubated with antibodies at 0°C
for 20 min followed by the addition of the labeled probe. Images were captured
and intensities of specific bands were measured using a BAS-2500 imaging
system (Fuji Film).
Cell viability assay. Three days posttransfection, siRNA-transfected 293 cells
were seeded at 1,000 cells/well in 96-well plates. Viability of the cells following 0,
1, 3, and 4 days of culture was assayed by staining with 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) re-
agent (Promega) and measuring the optical density at 490 nm.
RESULTS
Overexpression of NF90 and NF45 inhibits the processing
step to produce pre-miRNA during miRNA biogenesis. To
examine the effect of the NF90 and NF45 proteins on the
Drosha-mediated processing step in miRNA biogenesis, we
performed an in vitro pri-miRNA processing assay. WCEs
were prepared from 293T cells transfected with expression
plasmids for the NF90 family (NF90a, NF90b, NF110a, or
NF110b) and/or NF45. After radiolabeled pri-miR-30a was
incubated with WCEs and RNAs were extracted and loaded
onto a denaturing gel (Fig. 1A). The levels of pre-miR-30a
were measured with a densitometer (Fig. 1B). This analysis
showed that simultaneous expression of the NF90 and NF45
proteins markedly inhibited the cleavage of pri-miR-30a to
pre-miR-30a (Fig. 1A, compare lanes 2 to 7 and 8 to 11, and
B). In contrast, neither NF90 nor NF45 alone affected the
processing step relative to the mock-transfected control (Fig.
1A, compare lane 2 and lanes 3 to 7, and B). Immunoblot
analysis showed that expression of Drosha and DGCR8, which
play a critical role in cleavage of pri-miRNA to pre-miRNA,
was not altered by the overexpression of the NF90 and/or
NF45 proteins (Fig. 1C). These results suggest that the NF90-
NF45 complex may function as a negative regulator in the
processing step to produce pre-miRNA during miRNA bio-
genesis.
Pri-miRNAs accumulate in mammalian cells that overex-
press NF90 and NF45. To assess the ability of the NF90-NF45
complex to function as a negative regulator in the pri-miRNA
processing step, we measured the levels of pri-miRNAs in cells
that overexpressed NF90 and/or NF45. 293T cells were trans-
fected with expression plasmids for mock transfection or NF45
and/or NF90. RNAs were extracted and analyzed by qRT-PCR
with specific primers for three different, randomly chosen pri-
miRNAs. -Actin was used as an internal control. Cells trans-
fected with NF45 did not show induction of pri-miRNAs, and
the forced expression of NF90 resulted in a slight increase in
the pri-miRNAs (Fig. 2). Importantly, the amounts of all pri-
miRNAs were strikingly increased by overexpression of both
the NF90 and NF45 proteins (Fig. 2), whereas -actin expres-
sion was not affected by these proteins (Fig. 2, compare A to C
with D). These results indicate that pri-miRNAs specifically
accumulated upon overexpression of NF90 and NF45. We also
measured the levels of mature miRNAs, which were processed
from the pri-miRNAs analyzed in the experiment shown in Fig.
2, in NF90-NF45-overexpressing cells. However, we could not
observe any significant change in miRNA production by the
overexpression of NF90, either with or without NF45 (data not
shown). Several previous studies reported that mature
miRNAs are highly stable in cells (33, 40). Therefore, a de-
crease of mature miRNAs at a steady-state level may be diffi-
cult to detect.
We next tested whether the increase in pri-miRNAs by
NF90-NF45 overexpression is due to transcriptional activation.
For this purpose, we used a universal inhibitor of RNA poly-
merase II, -amanitin. Cells were mock transfected or trans-
fected with both NF90b and NF45 plasmids and subsequently
treated with -amanitin for 0, 6, 12, and 24 h. RNAs were
prepared from the cells and analyzed by RT-qPCR with spe-
cific primers for selected pri-miRNAs. These analyses indi-
cated that all the pri-miRNAs examined were significantly de-
creased in mock-transfected cells treated with -amanitin for
12 h (Fig. 3A and B) or 24 h (Fig. 3C), indicating that the
steady-state levels of pri-miRNAs are maintained by transcrip-
tional activation. In contrast, the -amanitin treatment of cells
overexpressing NF90b and NF45 did not significantly reduce
the levels of pri-miRNAs (Fig. 3), suggesting that transcrip-
tional activation is not the sole factor for the elevation of
pri-miRNAs by NF90-NF45 overexpression. These findings to-
gether with results of the in vitro pri-miRNAs processing assay
(Fig. 1) suggest that the inhibition of the Drosha-mediated
pri-miRNAs processing step by the NF90-NF45 complex
caused the accumulation of pri-miRNAs.
A previous study indicated that overexpressed Drosha asso-
ciates with NF90 and NF45 (13). This finding prompted us to
examine whether the accumulation of pri-miRNAs by overex-
pressed NF90-NF45 is influenced by the forced expression of
Drosha. However, no significant change in the accumulated
level of pri-miRNAs was observed in cells transfected with
NF90-NF45 and Drosha compared with NF90-NF45-overex-
pressing cells (Fig. 4A). We verified that Drosha was expect-
edly overexpressed upon transfection at the RNA and protein
levels (Fig. 4B). These results suggest that overexpressed
NF90-NF45 may disturb the accessibility of Drosha to pri-
miRNAs.
NF90 is retained in the nucleus during overexpression of the
NF90-NF45 complex. To examine the subcellular localization
of the NF90 family proteins in cells that overexpressed NF90
and NF45, we performed immunocytochemical staining. 293T
cells were mock transfected or transfected with plasmids for
NF90b or both NF90b and NF45 and stained with DAPI for
nuclear staining (Fig. 5, upper panels) and anti-NF90 antibody
(Fig. 5, middle panels). The lower panels show overlays of
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these two signals (Fig. 5, merge). As previously reported, en-
dogenous NF90 proteins were predominantly localized in the
nucleus (Fig. 5, first column). Importantly, enforced expression
of NF90b or both NF90b and NF45 did not affect the nuclear
localization of the NF90 family proteins (Fig. 5, second and
third columns). This indicates that the NF90 family proteins
are retained in the nucleus, even if NF90 and NF45 are exces-
sively expressed.
NF90 does not interact with the endogenous Drosha-
DGCR8 complex, but the NF90-NF45 complex binds endoge-
nous pri-miRNAs. To test whether the NF90 proteins associate
with endogenous Drosha in vivo, WCEs were prepared from
FIG. 1. Inhibition of pri-miRNA processing by coexpression of NF90 and NF45. (A) In vitro processing of pri-miR30a. Radiolabeled pri-miR-30a
was incubated with WCEs from 293T cells transfected with the indicated expression plasmids. RNA was isolated and separated on a 12% polyacrylamide
urea gel. Processing of pri-miR-30a was visualized by autoradiography. (B) Band intensities corresponding to the pre-miR-30a in panel A were measured
with a densitometer. Data represent the average of two independent experiments. Error bars indicate standard deviation. (C) Immunoblot analyses of
Drosha and DGCR8 in WCEs used for the in vitro pri-miR-30a processing assay. WCEs from 293T cells transfected with the indicated expression
plasmids were probed with anti-Drosha or anti-DGCR8 antibodies. Anti-Ku70 antibody was used as loading control.
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293T cells that were mock transfected or transfected with plas-
mids for both NF90b and NF45 and subjected to immunopre-
cipitation with anti-Drosha antibody or normal rabbit IgG. The
immunoprecipitates were analyzed by Western blotting with
anti-Drosha, anti-DGCR8, or anti-NF90 antibodies. As ex-
pected, Drosha interacted with DGCR8 in mock-transfected
cells and cells transfected with both NF90b and NF45 (Fig. 6A,
middle panels). However, NF90 did not associate with the
endogenous Drosha-DGCR8 complex in vivo (Fig. 6A, lower
panel). To confirm these results, we carried out a blue native
electrophoresis analysis, which is a powerful tool for analyzing
native protein complexes. WCEs prepared from 293T cells that
were mock transfected or transfected with both NF90b and
NF45 were subjected to native PAGE and immunoblotting to
determine whether the Drosha-DGCR8 complex and the
NF90-NF45 complex are distinct. As shown in Fig. 6B, the
mobility of the Drosha-containing complex was completely
consistent with that of DGCR8, and the NF90- and NF45-
containing complexes exhibited the same mobility (Fig. 6B).
These results show that Drosha forms a complex with DGCR8,
while NF90 associates with NF45. However, the mobility of
NF90-NF45 was clearly different from that of Drosha-DGCR8
(Fig. 6B). These observations, together with previously re-
ported data (13), suggest that the NF90-NF45 complex is not
included in the endogenous Drosha-DGCR8 complex, al-
though forced expression of Drosha associates with NF90 and
NF45 (13).
We next examined if the NF90-NF45 complex associates with
endogenous pri-miRNAs in vivo. WCEs from 293T cells that
were mock transfected or transfected with plasmids for Flag-
tagged NF90b and/or Flag-tagged NF45 were immunoprecipi-
tated with anti-Flag antibody. RNAs were recovered from the
immunoprecipitates and analyzed by RT-PCR with the specific
primers for pri-miRNAs. All the pri-miRNAs examined were
undetectable in no-template and no-reverse transcriptase samples
(Fig. 7, lanes 5 to 9). Of note, the NF90b-NF45 complex associ-
FIG. 2. Pri-miRNAs accumulate upon coexpression of NF90 and NF45. RNAs isolated from 293T cells transfected with the indicated
expression plasmids were analyzed for expression of pri-miRNAs by qRT-PCR with specific primers for (A) pri-let-7a-1, (B) pri-miR-15a16-1,
(C) pri-miR-21, or (D) -actin. -Actin was used as an internal control and for normalization of the data. These results were reproducible in three
independent transfection experiments. Data represent the averages of duplicate PCRs and the range.
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FIG. 3. Accumulation of pri-miRNAs by coexpression of NF90 and NF45 is not caused by transcriptional activation. 293T cells transfected with
the indicated expression plasmids were treated with -amanitin for 6, 12, or 24 h. The expression of pri-miRNAs was analyzed by qRT-PCR with
the specific primers for (A) pri-let-7a-1, (B) pri-miR-15a16-1, and (C) pri-miR-21. -Actin was used as an internal control and for normalization
of the data. These results were reproducible in two independent transfection experiments. Data represent the averages of triplicate PCRs with
ranges. P values were calculated by using the two-tailed Student’s t test.
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ated with all pri-miRNAs (Fig. 7, lane 4), whereas the NF45 or
NF90b proteins alone were not able to bind to the majority of
pri-miRNAs (Fig. 7, lanes 2 and 3). Interestingly, the number of
PCR cycles needed to detect pri-let-7a-1 was much lower than
that for other pri-miRNAs tested (35, versus 45 for other pri-
miRNAs), although the efficiency of PCR amplification for pri-
let-7a-1 was not higher than that for other pri-miRNAs. These
results suggest that the higher amount of pri-let-7a-1 was associ-
ated with NF90-NF45 compared to other pri-miRNAs. In addi-
tion, we measured the absolute amounts of pri-miRNAs in cells
transfected with NF90 and NF45 by qRT-PCR using plasmids
harboring cDNA for pri-miRNAs as standards. The results indi-
cated that the absolute amount of pri-let-7a-1 was about 3- to
30-fold higher than that of other pri-miRNAs (see Table S2 in the
supplemental material), implying that overexpressed NF90-NF45
has the ability to associate with endogenous pri-miRNAs depen-
dent on the abundance of each pri-miRNA.
The NF90-NF45 complex binds to pri- and pre-let-7a-1, and
the affinity of NF90-NF45 complex for pri-let-7a-1 is higher
than that of DGCR8 in vitro. To confirm the data from the in
vivo RNA-protein binding analysis (Fig. 7), we performed an
EMSA using recombinant proteins. We generated recombi-
nant NF90 (rNF90), rNF45, FL DGCR8, and dsRBDs of
DGCR8 in E. coli (see Fig. S1A in the supplemental material)
and used these proteins for an EMSA with pri-miRNAs or
pre-miRNA probe. Immunoblot analysis with anti-DGCR8 an-
tibody confirmed the existence of DGCR8 in our purified
rDGCR8 FL sample (see Fig. S1A in the supplemental mate-
rial). The EMSA probed with pri-let-7a-1 clearly showed that
rNF90-rNF45 bound to these RNAs in vitro (Fig. 8; see also
Fig. S1B in the supplemental material). However, we found
two major bands in these analyses (Fig. 8; see Fig. S1B [arrows
and asterisks] in the supplemental material). To determine
which band is the complex between rNF90 or rNF90-rNF45
FIG. 4. Forced expression of Drosha does not affect the accumulation of pri-miRNAs by NF90-NF45. (A) RNAs isolated from 293T cells
transfected with the indicated expression plasmids were analyzed for expression of pri-miRNAs by qRT-PCR with specific primers for pri-let-7a-1
and pri-miR-21. -Actin was used as an internal control and for normalization of the data. These results were reproducible in three independent
transfection experiments. Data represent the averages of triplicate PCRs with ranges. (B) RNA and WCEs were prepared from 293T cells
transfected with the indicated expression plasmids and analyzed by RT-PCR and immunoblot analysis, respectively. Intensities of specific bands
in the immunoblotting assay were measured with a densitometer and are presented as relative band intensities.
3760 SAKAMOTO ET AL. MOL. CELL. BIOL.
 by on June 15, 2009 
m
cb.asm
.org
D
ow
nloaded from
 
and RNAs, we carried out a supershift assay using anti-NF90
antibody. Addition of NF90 antibody resulted in the formation
of supershifted complex with the upper band (see Fig. S1B,
lanes 3 and 4, in the supplemental material), indicating that the
upper band is the complex of rNF90-rNF45 with RNAs. Under
this experimental condition, EMSA probed with pri-let-7a-1
and pri-miR-21 showed that the rNF90-rNF45 complex exhib-
ited 4.3-fold-higher binding activity for pri-let-7a-1 than pri-
miR-21 (see Fig. S1D, arrow, compare lanes 4 and 9, in the
supplemental material). We next examined if the NF90-NF45
complex discriminates between pri-miRNAs and pre-miRNAs.
An EMSA with pri- or pre-let-7a-1 indicated that the binding
activity of the rNF90-rNF45 complex to pre-let-7a-1 was com-
parable to that of this complex to pri-let-7a-1 (Fig. 8A, com-
pare lanes 2 and 6). Recent studies also showed that NF90,
either with or without NF45, binds to pre-let-7 in vitro (23, 57).
Therefore, these results suggest that the NF90-NF45 complex
selectively binds the stem-loop structure, which is a common
secondary structure of pri- and pre-miRNAs. Furthermore, we
tested whether the NF90-NF45 complex exhibits higher bind-
ing to pri-miRNA than with NF90 alone as shown in Fig. 7.
Figure 8B showed that the binding activity of rNF90-rNF45
to pri-let7a-1 was 1.8-fold higher than that of rNF90 alone
(compare lanes 3 and 7). NF45 alone did not exhibit the bind-
ing to pri-let-7a-1 (Fig. 8B, lanes 4 and 5). To confirm this
result, we performed rNF45 titrations in the presence of
rNF90. As expected, the binding activity of rNF90 was in-
creased according to the elevation of rNF45 concentration, but
not that of a control protein (GST) (see Fig. S1C in the sup-
plemental material, compare lanes 2 to 4 and 5 to 7).
Since the NF90-NF45 complex impairs pri-miRNA pro-
cessing and binds to pri-miRNA while these proteins do not
associate with endogenous Drosha-DGCR8, we hypothe-
sized that the binding of NF90-NF45 to pri-miRNAs re-
duces the accessibility of Drosha-DGCR8 to pri-miRNAs,
resulting in the inhibition of pri-miRNA processing. It is
known that DGCR8 recognizes the substrate pri-miRNAs,
whereas Drosha is responsible for cleavage in Drosha-
DGCR8-mediated pri-miRNA processing (21). Therefore,
we compared the difference in the binding activity to pri-
let-7a-1 between NF90-NF45 and DGCR8. rDGCR8 FL
showed two bands on the EMSA when probed with pri-let-
7a-1 (Fig. 8C, lanes 9 and 10). Thus, we performed a super-
shift assay using anti-DGCR8 antibody, which recognizes
the DGCR8 C-terminal region containing dsRBDs. In this
analysis, both bands disappeared with the addition of anti-
DCGR8 antibody (see Fig. S1B in the supplemental mate-
rial, compare lanes 5 and 6 with 7 and 8), demonstrating that
the two bands were the complex of rDGCR8 FL with pri-
miRNA. Under this experimental condition, we compared
the binding activities of rNF90-rNF45 and rDGCR8 FL to
pri-miRNA. As shown in Fig. 8C, rNF90-rNF45 clearly ex-
FIG. 5. Localization of endogenous and overexpressed NF90 family proteins. 293T cells transfected with the indicated expression plasmids were
stained with DAPI (upper panels) and anti-NF90 antibody (middle panels). Lower panels show overlays of these two signals.
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hibited a greater binding activity to pri-let-7a-1 than
rDGCR8 FL (compare lanes 2 to 4 and 5 to 7). To confirm
this result, we performed an EMSA using rDGCR8-
dsRBDs. Titration of rDGCR8-dsRBDs indicated the for-
mation of a complex between rDGCR8-dsRBDs and pri-let-
7a-1 (Fig. 8D). As shown in Fig. 8E, the complex between
rDGCR8-dsRBDs and pri-miRNA was replaced by the
NF90-NF45-pri-miRNA complex at lower concentrations of
rNF90-rNF45 (1.2 to 4.8 M) compared with that of
rDGCR8-dsRBDs (9.6 M). These results suggest that
NF90-NF45 might preferentially bind to pri-let-7a-1 even in
the presence of Drosha-DGCR8 under the condition of
NF90-NF45 overexpression.
Knockdown of NF90 leads to a reduction of pri-let-7a-1 and
an increase of mature let-7a-1 and causes growth suppression
of transformed cells. To confirm the function of the NF90-NF45
complex as a negative regulator in miRNA biogenesis, we mea-
sured the levels of pri-miRNAs and mature miRNAs which were
produced from tested pri-miRNAs in NF90 knockdown cells.
Transfection of siRNAs targeting the NF90 family proteins re-
sulted in75% inhibition of the expression of endogenous NF90
family proteins (Fig. 9A). As expected, we observed a significant
decrease in pri-let-7a-1 in the NF90 knockdown cells (Fig. 9B). In
accordance with the decrease in pri-let-7a-1, mature let-7a was
increased in cells that were depleted of NF90 (Fig. 9C). However,
knockdown of NF90 did not significantly affect the levels of other
FIG. 6. NF90 and NF45 do not interact with endogenous Drosha-DGCR8. (A) WCEs from 293T cells transfected with the indicated expression
plasmids were immunoprecipitated with anti-Drosha antibody or normal rabbit IgG. The immunoprecipitates were probed with anti-Drosha,
anti-DGCR8, or anti-NF90 antibodies. Arrows indicate the specific target proteins. (B) WCEs from 293T cells transfected with the indicated
expression plasmids were subjected to blue native page analysis, followed by immunoblot analysis using anti-Drosha, anti-DGCR8, anti-NF90, or
anti-NF45 antibodies. Arrows indicate the complexes containing the specific target proteins.
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FIG. 7. The NF90-NF45 complex binds to endogenous pri-miRNAs in vivo. The experimental procedure is indicated in the upper part. WCEs
from 293T cells transfected with indicated FLAG-tagged proteins were immunoprecipitated with anti-FLAG antibody. RNAs were isolated from
the immunoprecipitates and analyzed by RT-PCR with specific primers for pri-let-7a-1, pri-miR-15a16-1, pri-miR-21, or pri-miR-30a. The
numbers of PCR cycles for detection of pri-let-7a-1 and pri-miR-15a16-1, pri-miR-21, and pri-miR-30a were 35 and 45 cycles, respectively.
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pri-miRNAs and mature miRNAs (Fig. 9B and C). These results,
together with protein-RNA binding assays (see Fig. S1D in the
supplemental material), suggest that processing of pri-miRNAs
having high affinity for the NF90-NF45 complex into mature
miRNAs may be specifically prevented by these proteins.
Several reports have indicated that let-7a has a potent anti-
proliferative activity in cultured cell lines (1, 25). This finding
prompted us to test if NF90-NF45 participates in the control of
cell proliferation. Knockdown of NF90 resulted in a significant
reduction in growth rates of 293 cells (Fig. 10). Since the level
of mature let-7a was elevated in NF90 knockdown cells, as
shown in Fig. 9C, these observations suggest that NF90-NF45
might control cell proliferation via the regulation of mature
let-7a production.
DISCUSSION
The miRNA processing machinery has been relatively well
characterized. The basic miRNA factors include Drosha,
DGCR8, Exportin-5, Dicer, and Argonaute (Ago). In addition,
FIG. 8. NF90 binds to pri- and pre-miRNAs in vitro. (A) EMSA performed with pri- and pre-let-7a probes and 2.4 M each rNF90 and
rNF45, in the absence (-) or presence of a 25- or 50-fold excess of unlabeled competitor RNA as indicated. (B) EMSA performed with the
pri-let-7a probe and rNF90 alone, rNF45 alone, or both rNF90 and rNF45 proteins at the indicated protein concentrations. (C) EMSA
performed with the pri-let-7a probe and rNF90-rNF45 and rDGCR8 FL at the indicated protein concentrations. Intensities of bands
corresponding to the specific RNA-protein complexes indicated by upper arrows were measured with a densitometer and are presented as
relative band intensities. Lanes 8 to 10 indicate the same picture after a long exposure. (D) EMSA performed with the pri-let-7a probe and
rDGCR8 dsRBDs at the indicated protein concentrations. (E) EMSA performed using rDGCR8 dsRBDs and rNF90-rNF45 at the indicated
protein concentrations. The specific RNA-protein complexes are indicated by arrows. Asterisks indicate nonspecific bands.
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p68 and p72 DEAD-box RNA helicase subunits, DDX5 and
DDX17, human immunodeficiency virus transactivating re-
sponse RNA binding protein, and PKR-activating protein have
been reported as miRNA processing factors (6, 9, 18, 34). Like
NF90 and NF45, DDX5 and DDX17 associate with overex-
pressed Drosha (13), but DDX5 and DDX17 facilitate the
Drosha-DGCR8-mediated pri-miRNA processing reaction
(9), while NF90 and NF45 inhibit the pri-miRNA processing
(this study). Transactivating response RNA binding protein
and PKR-activating protein function as bridging molecules
between Dicer and Ago, but they do not show any effect on the
Dicer processing reaction (6, 34). Notably, knockdown of these
proteins reduces mature miRNA production (6, 9, 34), indi-
cating that these miRNA processing factors are positive regu-
lators for miRNA biogenesis. In contrast, negative regulatory
events in the miRNA processing pathways are largely un-
known.
In this study, we have shown that the forced expression of
NF90 and NF45 impairs the Drosha-mediated pri-miRNA pro-
cessing step in vitro (Fig. 1). Furthermore, pri-miRNAs accu-
mulated in cells that overexpressed NF90 and NF45, and the
accumulation was not due to transcriptional activation (Fig. 2
and 3). Interestingly, the enforced expression of Drosha, which
plays a crucial role in cleavage of pri-miRNA to pre-miRNA,
FIG. 8—Continued.
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had no apparent effect on the accumulation (Fig. 4). In addi-
tion, the NF90-NF45 complex did not interact with the endog-
enous Drosha-DGCR8 complex (Fig. 6). On the other hand, in
vivo and in vitro RNA-protein binding assays demonstrated
that the NF90-NF45 complex bound to pri-miRNAs (Fig. 7
and 8; see also Fig. S1 in the supplemental material). Partic-
ularly, pri-let-7a-1 was found to show higher binding with
NF90-NF45 than pri-miR-21 (see Fig. S1D in the supplemen-
tal material). Notably, knockdown of NF90 caused the de-
crease of pri-let-7a-1 and the increment in mature let-7a (Fig.
FIG. 9. Knockdown of NF90 decreases pri-miRNA and increases mature miRNA. (A) WCEs were prepared from 293 cells transfected with
the indicated siRNAs and analyzed by immunoblotting with anti-NF90 and anti--tubulin antibodies. Intensities of specific bands were measured
with a densitometer and are presented as relative band intensities. (B) RNAs were isolated from 293 cells transfected with the indicated siRNAs
and analyzed for the amount of pri-miRNAs by qRT-PCR with specific primers for pri-let-7a-1, pri-miR-21 and pri-miR-15a16-1. -Actin was
used as an internal control and for normalization of the data. siCTL, negative control siRNA; siNF90-1 and -2, siRNA targeting NF90. These
results were reproducible in two independent transfection experiments. Data represent the averages of triplicate PCRs with ranges. P values were
calculated by a two-tailed Student’s t test. (C) RNAs were isolated from 293 cells transfected with the indicated siRNAs and analyzed for the
amount of mature let-7a, miR-21 and miR-15a miRNAs using the TaqMan microRNA assay. RNU6B was used as an internal control and for
normalization of the data. These results were reproducible in two independent transfection experiments. Data represent the averages of triplicate
PCRs with ranges. P values were calculated by the two-tailed Student’s t test.
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9). Therefore, these findings suggest that the binding of NF90-
NF45 to pri-miRNAs may reduce the accessibility of the Mi-
croprocessor complex to pri-miRNAs, resulting in the reduc-
tion of miRNA production.
The NF90 and NF45 mRNAs are ubiquitously expressed in
human and murine tissues (50, 60). However, protein expres-
sion levels of NF90 and NF45 are restricted. In both humans
and mice, the NF90 family proteins are minimally expressed in
lung, spleen, skeletal muscle, kidney, and liver, whereas high
expression is seen in brain, testis, ovary, and thymus (50, 52) (S.
Sakamoto, unpublished data). NF45 is also minimally ex-
pressed in heart, lung, spleen, skeletal muscle, and liver, but it
is abundantly expressed in brain, testis, kidney, and thymus
(60; Sakamoto, unpublished). The highest amounts of both
proteins are seen in immortalized cell lines derived from
uterus, kidney, leukocyte, fibroblast, stomach, and liver (50, 60;
Sakamoto, unpublished). These observations suggest that the
expression of the NF90 and NF45 proteins in undifferentiated
cells may be much higher than that in differentiated cells.
Indeed, the thymus and testis, in which the highest levels of the
NF90 and NF45 proteins are seen, are comprised largely of
cells undergoing differentiation, while lung, spleen, skeletal
muscle, kidney, and liver are comprised largely of terminally
differentiated cells. Furthermore, our previous results showed
that higher levels of NF90 expression were detected in undif-
ferentiated leukemia cells compared with phorbol ester-in-
duced differentiated cells (47).
Numerous studies have demonstrated that miRNAs are as-
sociated with tumorigenesis. It is noteworthy that expression of
a high copy number of miRNAs is reduced in tumor tissues and
in transformed cell lines compared with normal tissues (10,
39). Interestingly, primary miRNA transcripts are not reduced
in tumors, suggesting that the reduction of miRNAs in cancers
is due to the altered regulation of the pri-miRNA processing
(56). In fact, knockdown of Drosha, DGCR8, or Dicer, which
are crucial factors for pri- and pre-miRNA processing, en-
hances tumor formation (30). However, expression of these
factors is not dependent upon cytodifferentiation (39, 56).
These observations suggest that the reduction of miRNAs in
tumors might be due either to posttranslational modifications
of the miRNA processing machinery or to the involvement of
another miRNA-processing regulatory factor(s).
let-7 miRNA, which is a founding member of the miRNA
family, is composed of 12 variants, let-7a-1 to let-7i and miR-
98. Among them, mature let-7a, -7d, -7f-1, -7f-2, -7i, and
miR-98 are detectable only in highly differentiated human and
mouse embryonic cells, although the primary transcripts of
those miRNAs are expressed in both undifferentiated and dif-
ferentiated cells (54, 56). Several studies also reported that the
level of let-7 family is decreased in tumor tissues compared
with adjacent normal tissues (1, 26, 55, 59) and has the ability
to inhibit proliferation of transformed cell lines (1, 25). Fur-
thermore, it is known that a decrease in the level of let-7 family
causes an increase in the expressions of RAS, c-MYC, and
HMGA2, resulting in tumorigenesis (1, 26, 37, 42, 49). It has
been thought that the alteration of let-7 family level according
to cytodifferentiation is due to posttranscriptional regulation
(54, 56). Indeed, recent studies reported that lin28 functions as
a negative regulator for production of mature let-7 family by
blockade of Drosha processing or Dicer processing (23, 57).
The present study has shown that depletion of NF90 results
in a reduction of pri-let-7a-1 accompanied by an increase in
mature let-7a (Fig. 9) and growth retardation in transformed
cells (Fig. 10). A recent study also indicated that growth sup-
pression is observed in NF90 or NF45 knockdown HeLa cells
(15). Analyses of NF90 and NF45 expression profiles suggest
that these proteins could be more highly expressed in undif-
ferentiated than differentiated cells (47, 50, 52, 60). In addi-
tion, we have found that NF90-NF45 expression exhibits
significant elevation in human tumor tissues bearing hepato-
cellular carcinoma compared with adjacent normal tissues (un-
published data). The elevation of NF90 has been also found in
lung cancer tissues (16). Moreover, mature let-7a is downregu-
lated in lung cancer and hepatocellular carcinoma compared
with adjacent normal tissues or liver cirrhosis (11, 26, 55; Saka-
moto, unpublished). It is therefore possible that the repression
of let-7 is likely due to the high expression of the NF90 and
NF45 proteins in tumor cells, together with lin28, resulting in
the accelerated growth of the cells. Elucidation of the roles for
these proteins in the downregulation of let-7, followed by the
control of cell growth in tumors, will be of interest but will
require extensive work in the future.
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